Wolfgang Muster

2.2k total citations
26 papers, 742 citations indexed

About

Wolfgang Muster is a scholar working on Computational Theory and Mathematics, Cancer Research and Small Animals. According to data from OpenAlex, Wolfgang Muster has authored 26 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Computational Theory and Mathematics, 11 papers in Cancer Research and 7 papers in Small Animals. Recurrent topics in Wolfgang Muster's work include Carcinogens and Genotoxicity Assessment (11 papers), Computational Drug Discovery Methods (11 papers) and Animal testing and alternatives (7 papers). Wolfgang Muster is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), Computational Drug Discovery Methods (11 papers) and Animal testing and alternatives (7 papers). Wolfgang Muster collaborates with scholars based in Switzerland, United States and United Kingdom. Wolfgang Muster's co-authors include Stephan Kirchner, Lutz Müller, Alexander Breidenbach, Axel Pähler, Holger Fischer, Alessandro Brigo, Elmar Gocke, Silvio Albertini, Susanne Glowienke and Krista L. Dobo and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Drug Discovery Today.

In The Last Decade

Wolfgang Muster

25 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Muster Switzerland 13 324 220 192 110 85 26 742
Susanne Glowienke Switzerland 16 221 0.7× 136 0.6× 237 1.2× 69 0.6× 172 2.0× 28 700
Krista L. Dobo United States 20 199 0.6× 289 1.3× 420 2.2× 67 0.6× 241 2.8× 42 947
J. J. Langowski United Kingdom 7 352 1.1× 221 1.0× 57 0.3× 76 0.7× 48 0.6× 8 656
Todor Pavlov Bulgaria 15 440 1.4× 173 0.8× 56 0.3× 148 1.3× 205 2.4× 22 804
Steve Gutsell United Kingdom 15 255 0.8× 160 0.7× 49 0.3× 122 1.1× 216 2.5× 33 649
Orest T. Macina United States 14 203 0.6× 137 0.6× 110 0.6× 53 0.5× 121 1.4× 27 528
Jay Russell Niemelä Denmark 10 294 0.9× 103 0.5× 48 0.3× 106 1.0× 186 2.2× 16 631
Kirk Arvidson United States 11 223 0.7× 98 0.4× 59 0.3× 81 0.7× 132 1.6× 13 444
G Klopman United States 11 218 0.7× 110 0.5× 197 1.0× 28 0.3× 113 1.3× 18 433
Gilles Klopman United States 12 212 0.7× 134 0.6× 196 1.0× 22 0.2× 120 1.4× 19 533

Countries citing papers authored by Wolfgang Muster

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Muster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Muster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Muster more than expected).

Fields of papers citing papers by Wolfgang Muster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Muster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Muster. The network helps show where Wolfgang Muster may publish in the future.

Co-authorship network of co-authors of Wolfgang Muster

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Muster. A scholar is included among the top collaborators of Wolfgang Muster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Muster. Wolfgang Muster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palazzi, Xavier, Armelle Grevot, Magali Guffroy, et al.. (2024). Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies. Regulatory Toxicology and Pharmacology. 150. 105632–105632. 8 indexed citations
2.
Foster, Robert S., Alessandro Brigo, Wolfgang Muster, et al.. (2023). Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessments. Regulatory Toxicology and Pharmacology. 144. 105490–105490. 3 indexed citations
3.
Brigo, Alessandro, et al.. (2022). Increasing the Value of Data Within a Large Pharmaceutical Company Through In Silico Models. Methods in molecular biology. 2425. 637–674. 2 indexed citations
4.
Bercu, Joel P., Thomas H. Broschard, Catrin Hasselgren, et al.. (2022). Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls). PDA Journal of Pharmaceutical Science and Technology. 76(5). 369–383. 7 indexed citations
5.
Hasselgren, Catrin, Joel P. Bercu, Kevin P. Cross, et al.. (2020). Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates. Regulatory Toxicology and Pharmacology. 118. 104807–104807. 26 indexed citations
6.
Schnider, Patrick, Caterina Bissantz, Andreas Bruns, et al.. (2020). Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder. Journal of Medicinal Chemistry. 63(4). 1511–1525. 39 indexed citations
7.
Zeller, Andreas, Alessandro Brigo, Andreas Brink, et al.. (2019). Genotoxicity Assessment of Drug Metabolites in the Context of MIST and Beyond. Chemical Research in Toxicology. 33(1). 10–19. 9 indexed citations
8.
Weidolf, Lars, Thomas Andersson, Joel P. Bercu, et al.. (2019). Qualification of impurities based on metabolite data. Regulatory Toxicology and Pharmacology. 110. 104524–104524. 12 indexed citations
9.
Brigo, Alessandro & Wolfgang Muster. (2016). The Use of In Silico Models Within a Large Pharmaceutical Company. Methods in molecular biology. 1425. 475–510. 1 indexed citations
10.
Barber, Chris, Alexander Amberg, Laura Custer, et al.. (2015). Establishing best practise in the application of expert review of mutagenicity under ICH M7. Regulatory Toxicology and Pharmacology. 73(1). 367–377. 51 indexed citations
11.
Bauer, Daniel, Ann De Smedt, Mark H. Kleinman, et al.. (2013). Standardized UV–vis spectra as the foundation for a threshold-based, integrated photosafety evaluation. Regulatory Toxicology and Pharmacology. 68(1). 70–75. 18 indexed citations
12.
Sutter, Andreas, Alexander Amberg, Scott Boyer, et al.. (2013). Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 67(1). 39–52. 88 indexed citations
13.
Dobo, Krista L., Nigel Greene, Charlotta Fred, et al.. (2012). In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regulatory Toxicology and Pharmacology. 62(3). 449–455. 62 indexed citations
14.
Moore, Martha M., Masamitsu Honma, Julie Clements, et al.. (2011). Suitable top concentration for tests with mammalian cells: Mouse lymphoma assay workgroup. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 723(2). 84–86. 13 indexed citations
15.
Muster, Wolfgang. (2003). Structure-activity relationship of oxadiazoles and allylic structures in the Ames test: an industry screening approach. Mutagenesis. 18(4). 321–329. 5 indexed citations
16.
Moore, Martha M., Masamitsu Honma, Julie Clements, et al.. (2000). Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup report. Environmental and Molecular Mutagenesis. 35(3). 185–190. 22 indexed citations
17.
Gocke, Elmar, et al.. (1998). The photomutagenicity of fluoroquinolones and other drugs. Toxicology Letters. 102-103. 375–381. 33 indexed citations
18.
Albertini, Silvio, Michael Bös, Elmar Gocke, et al.. (1998). Suppression of mutagenic activity of a series of 5HT2C receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay. Mutagenesis. 13(4). 397–403. 10 indexed citations
19.
Muster, Wolfgang, et al.. (1997). P XVII A.19 Mutagenicity evaluation of Genistein, an anticarcinogenic isoflavone present in soybeans. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 379(1). S170–S170. 1 indexed citations
20.
Albertini, Silvio, et al.. (1995). Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis. 10(4). 343–351. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Glowienke Breakdown of academic impact, for papers by Krista L. Dobo Breakdown of academic impact, for papers by J. J. Langowski Breakdown of academic impact, for papers by Todor Pavlov Breakdown of academic impact, for papers by Steve Gutsell Breakdown of academic impact, for papers by Orest T. Macina Breakdown of academic impact, for papers by Jay Russell Niemelä Breakdown of academic impact, for papers by Kirk Arvidson Breakdown of academic impact, for papers by G Klopman Breakdown of academic impact, for papers by Gilles Klopman
Rankless by CCL
2026